Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Generation of a fibroblast chemotactic factor in serum by activation of complement.
A E Postlethwaite, … , R Snyderman, A H Kang
A E Postlethwaite, … , R Snyderman, A H Kang
Published November 1, 1979
Citation Information: J Clin Invest. 1979;64(5):1379-1385. https://doi.org/10.1172/JCI109595.
View: Text | PDF
Research Article

Generation of a fibroblast chemotactic factor in serum by activation of complement.

  • Text
  • PDF
Abstract

When serum complement is activated by either the classical or alternative pathways, a factor with an apparent 80,000 mol wt is generated that is chemotactic for human dermal fibroblasts. The origin of this serum-derived chemotactic factor (SDCF) is not known; however, it may be a cleavage product from C5 because it is inactivated by monospecific antiserum to human C5, and it is not generated when the complement system is activated in human serum deficient in C5. SDCF is not chemotactic for human neutrophils or monocytes. Because SDCF is generated when serum complement is activated, it may function in vivo to attract connective tissue fibroblasts to sites of inflammatory reactions in which the complement system participates.

Authors

A E Postlethwaite, R Snyderman, A H Kang

×

Total citations by year

Year: 2012 2011 2008 2001 2000 1998 1996 1994 1993 1992 1991 1989 1988 1987 1986 1985 1984 1983 1982 1981 Total
Citations: 1 1 2 1 2 2 1 2 4 3 5 3 3 3 2 6 5 5 5 4 60
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (60)

Title and authors Publication Year
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee
Annual Reports in Medicinal Chemistry Volume 46 2011
Novartis Foundation Symposia
EJ Campbell
Ciba Foundation Symposium 44 - Research and Medical Practice: Their Interaction 2008
Novartis Foundation Symposia: Ciba/Fibrosis
GR Grotendorst, L Paglia, C Mcivor, S Barsky, Y Martinet, D Pencev
Novartis Foundation Symposia: Ciba/Fibrosis 2008
Inflammation
JA Hunt
Encyclopedia of Materials Science and Technology 2001
Fibroblast biology. Signals targeting the synovial fibroblast in arthritis
YT Konttinen, TF Li, M Hukkanen, J Ma, JW Xu, I Virtanen
Arthritis research 2000
Principles of Tissue Engineering
AS Xu, AS Xu, TL Luntz, JM Macdonald, JM Macdonald, H Kubota, E Hsu, RE London, LM Reid
Principles of Tissue Engineering 2000
Understanding and controlling the scarring response: The contribution of histology and microscopy
JT Daniels, NL Occleston, JG Crowston, MF Cordeiro, RA Alexander, M Wilkins, R Porter, R Brown, PT Khaw
Microscopy Research and Technique 1998
Repair of the airway epithelium: Potential opportunities for therapeutic intervention in airway disease
SI Rennard
Allergology International 1998
PEPTIDE GROWTH FACTORS AND OXYGEN IN THE HEALING CASCADE
TH Faerber, TS Hiles
Oral and Maxillofacial Surgery Clinics of North America 1996
Activation and suppression of fibroblast function
PT Khaw, NL Occleston, G Schultz, I Grierson, MB Sherwood, G Larkin
Eye 1994
The Sclera
CS Foster, MS de la Maza
1994
Fibroblast migration and proliferation during in vitro wound healing
T Schreier, E Degen, W Baschong
Research in Experimental Medicine 1993
Effects of high calcium concentration on the functions and interactions of osteoblastic cells and monocytes and on the formation of osteoclast-like cells
T Sugimoto, M Kanatani, J Kano, H Kaji, T Tsukamoto, T Yamaguchi, M Fukase, K Chihara
Journal of Bone and Mineral Research 1993
Fibroblast migration and proliferation during in vitro wound healing: A quantitative comparison between various growth factors and a low molecular weight blood dialyzate used in the clinic to normalize impaired wound healing
T Schreier, E Degen, W Baschong
Research in Experimental Medicine 1993
Biology of Dermal Wound Repair
RA Clark
Dermatologic Clinics 1993
The effects of indomethacin on fibroblast chemotaxis
GW Kalmus, JE Poulos, CW O'Rear
General Pharmacology: The Vascular System 1992
Mononuclear Phagocytes
R van Furth
1992
The Peritoneum
GS diZerega, KE Rodgers
1992
Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122
AE Postlethwaite, JM Seyer
Journal of Clinical Investigation 1991
Mechanisms of tubulointerstitial fibrosis
GS Kuncio, EG Neilson, T Haverty
Kidney International 1991
Mesothelial Cells Produce a Chemoattractant for Lung Fibroblasts: Role of Fibronectin
M Kuwahara, M Kuwahara, KE Bijwaard, DM Gersten, CA Diglio, E Kagan
American journal of respiratory cell and molecular biology 1991
Platelet-derived growth factor B chain homodimer enhances chemotaxis and DNA synthesis in normal osteoblast-like cells (MC3T3-E1)
T Tsukamoto, T Matsui, M Fukase, T Fujita
Biochemical and Biophysical Research Communications 1991
Interleukin-1 enhances the response of osteoblasts to platelet-derived growth factor through the alpha receptor-specific up-regulation
T Tsukamoto, T Matsui, H Nakata, M Ito, T Natazuka, M Fukase, T Fujita
The Journal of biological chemistry 1991
Effect of scatter factor on motility of epithelial cells and fibroblasts
M Stoker
Journal of Cellular Physiology 1989
Bronchial Epithelial Cells Produce Lung Fibroblast Chemotactic Factor: Fibronectin
S Shoji, KA Rickard, RF Ertl, RA Robbins, J Linder, SI Rennard
American journal of respiratory cell and molecular biology 1989
Studies in fetal wound healing: II. A fetal environment accelerates fibroblast migration in vitro
MT Longaker, MR Harrison, JC Langer, TM Crombleholme, ED Verrier, R Spendlove, R Stern
Journal of Pediatric Surgery 1989
Transforming Growth Factors in the Regulation of Malignant Cell Growth and Invasion
J Keski-Oja, AE Postlethwaite, HL Moses
Cancer Investigation 1988
Decline of Fibroblast Chemotaxis with Age of Donor and Cell Passage Number
A Albini, B Pontz, M Pulz, G Allavena, H Mensing, PK Müller
Collagen and Related Research 1988
The Molecular and Cellular Biology of Wound Repair
RA Clark, PM Henson
1988
Identification of a Protein in Sera of Normal Humans That Inhibits Fibroblast Chemotactic and Random Migration In Vitro
ME Ochs, AE Postlethwaite, AH Kang
Journal of Investigative Dermatology 1987
Conformational studies of synthetic tripeptide chemoattractants
G Vertuani, S Spisani, M Boggian, S Traniello, A Scatturin
International Journal of Peptide and Protein Research 1987
Normal rabbit aqueous humour, fibronectin, and fibroblast conditioned medium are chemoattractant to Tenon's capsule fibroblasts
JP Joseph, I Grierson, RS Bartholomew
Eye 1987
Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B
R M, WF Skogen, GL Griffin, GD Wilner
Journal of Clinical Investigation 1986
Generation and characterization of a neutrophil-derived inhibitor of fibroblast chemotaxis
H Mensing, BM Czarnetzki
Archives of Dermatological Research 1986
Bedeutung der Fibroblasten-Chemotaxis für Wundheilung und Tumorzellevasion
H Mensing
Klinische Wochenschrift 1985
SV40 transformed fibroblasts recognize the same 140 kD fibronectin chemotactic fragment as non-transformed cells
A Albini, G Allavena, H Richter, BF Pontz, S Parodi, L Santi
Experientia 1985
Macrophage chemotaxis in experimental tooth movement in the rat
C Nixon, G King
Archives of Oral Biology 1985
Cutaneous tissue repair: Basic biologic considerations. I
RA Clark
Journal of the American Academy of Dermatology 1985
Wound Healing 1985: An Update
SV Pollack
The Journal of Dermatologic Surgery and Oncology 1985
Immunology of Rheumatic Diseases
S Gupta, N Talal
1985
Induction of fibroblast proliferation by interleukin-1 derived from human monocytic leukemia cells
AE Postlethwaite, LB Lachman, AH Kang
Arthritis & Rheumatism 1984
Alteration of the chemotactic response of NIH/3T3 cells to PDGF by growth factors, transformation, and tumor promoters
GR Grotendorst
Cell 1984
Cellular and molecular mechanisms in wound healing: Selected concepts
WC Lambert, PJ Cohen, KM Klein, MW Lambert
Clinics in Dermatology 1984
Keratophakia and Keratomileusis
JV Jester, MM Rodrigues, RA Villasenor, DJ Schanzlin
Ophthalmology 1984
In vitro lessons for wound healing
BA Gilchrest
Clinics in Dermatology 1984
Migration by haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin
JB McCarthy, SL Palm, LT Furcht
The Journal of Cell Biology 1983
Fibronectin mediates cell attachment to C1q: a mechanism for the localization of fibrosis in inflammatory disease
SI Rennard, YF Chen, RA Robbins, JE Gadek, RG Crystal
Clinical & Experimental Immunology 1983
Chemotactic activity of platelet alpha granule proteins for fibroblasts
R M, GL Griffin, JS Huang, DA Walz, TF Deuel
The Journal of Cell Biology 1983
A quantitative in vitro study of fibroblast and endothelial cell migration in response to serum and wound fluid
SU Orredson, DR Knighton, H Scheuenstuhl, TK Hunt
Journal of Surgical Research 1983
Leukocyte Locomotion and Chemotaxis
HU Keller, GO Till
1983
Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides
R M, GL Griffin, RP Mecham
Journal of Clinical Investigation 1982
Platelet-derived growth factor is a chemoattractant for vascular smooth muscle cells
GR Grotendorst, T Chang, HE Sepp�, HK Kleinman, GR Martin
Journal of Cellular Physiology 1982
Inflammatory myopathy: A review of etiologic and pathogenetic factors
JN Whitaker
Muscle & Nerve 1982
Tumor Invasion and Metastasis
LA Liotta, IR Hart
1982
Themotaxis of metastatic tumor cells
J Varani
Cancer and Metastasis Reviews 1982
Comparison of the chemotactic responsiveness of two fibrosarcoma subpopulations of differing malignancy
FW Orr, J Varani, J Delikatny, N Jain, PA Ward
The American Journal of Pathology 1981
Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor
GR Grotendorst, HE Seppä, HK Kleinman, GR Martin
Proceedings of the National Academy of Sciences 1981
Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment
AE Postlethwaite, J Keski-Oja, G Balian, AH Kang
Journal of Experimental Medicine 1981
Responses of normal and malignant cells to collagen, collagen-derived peptides and the C5-related tumor cell chemotactic peptide
JA Wass, J Varani, GE Piontek, PA Ward, FW Orr
Cell Differentiation 1981

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts